Collectively, data herein provide a mechanistic rationale for stromal AR loss in aggressive PCa and suggest that adjuvant targeting of the YAP1-TGFβ signaling axis may improve patient outcome. The gene discussed is TGFB1; the disease is posterior cortical atrophy.